| 1. |
2024
Fang TY,Lin PH,Ko Y,Wu CC,Wang H,Liao WC, Wang PC.
Validation of the Chinese Version of the Speech, Spatial, and Qualities of Hearing Scale for Parents and Children
. Ear Hear
.2024
;(45):1362-1368
|
|
| 2. |
2024
Tseng TH,Chiang SC,Hsu JC,Ko Y.
Cost-effectiveness analysis of granulocyte colony-stimulating factors for the prophylaxis of chemotherapy-induced febrile neutropenia in patients with breast cancer in Taiwan
. PLoS One
.2024
;(19):e0303294
|
|
| 3. |
2024
Lin TH,Lin PH,Fang TY,Wu CC,Wang PC,Ko Y.
Cost-Utility Analysis of Bilateral Cochlear Implants for Children With Severe-to-Profound Sensorineural Hearing Loss in Taiwan
. Ear Hear
.2024
|
|
| 4. |
2024
Chang YW,Kuo CK,Chang CL,Hsu JC,Ko Y.
Effectiveness and Safety of Regorafenib and TAS-102 in Patients with Metastatic Colorectal Cancer: A Nationwide Population-Based Study in Taiwan
. Cancer Res Treat
.2024
|
|
| 5. |
2023
Hsu SW,Chiang SC,Hsu JC,Ko Y.
Prescription patterns of granulocyte colony-stimulating factors in patients with breast cancer: A real-world study
. PLoS One
.2023
;(18):e0288642
|
|
| 6. |
2023
Chen YW,Lin PH,Fang TY,Wu CC,Wang PC,Wang H, Ko Y.
Health Utilities of Bilateral Severe-to-Profound Hearing Loss with Assistive Devices
. Healthcare (Basel)
.2023
;(11):1649
|
|
| 7. |
2022
Yeh Y,Chen C,Ko Y.
Effectiveness and cost-effectiveness of trastuzumab emtansine in women with HER2-positive locally advanced or metastatic breast cancer: A systematic review and meta-analysis
. J Cancer Res Ther
.2022
;(18):1061-1072
|
|
| 8. |
2022
Chen X,Wang CY,Ko Y.
An investigation of physicians' prescribing behaviors related to antidiabetic agents for Type 2 diabetes mellitus patients and associated factors in Taiwan
. Curr Med Res Opin
.2022
|
|
| 9. |
2022
Wu YS,Chen C,Wang LC,Jian LS,Ko Y.
Talent cultivation in health technology assessment: an expert survey
. BMC Med Educ
.2022
;(22):157-162
|
|
| 10. |
2021
Cardiovascular outcomes and healthcare costs of liraglutide versus basal insulin for type 2 diabetes patients at high cardiovascular risk
. Sci Rep
.2021
;(11):1430
|
|
| 11. |
2021
Effectiveness and healthcare costs of eribulin versus capecitabine among metastatic breast cancer patients in Taiwan
. Breast
.2021
;(57):18-25
|
|
| 12. |
2021
An evaluation of the healthcare costs associated with adverse events in patients with breast cancer.
. Int J Health Plann Manage
.2021
;(36):1465-1475
|
|
| 13. |
2021
An evaluation of the healthcare costs of metastatic breast cancer: A retrospective matched cohort study.
. Medicine (Baltimore)
.2021
;(100):e27567
|
|
| 14. |
2021
Chen CC,Chen JH,Chen CL,Lai TJ,Ko Y.
Health Utilities in Patients with Type 2 Diabetes in Taiwan
. Healthcare (Basel)
.2021
;(9):1672-1680
|
|
| 15. |
2021
Poon SY,Hsu JC,Ko Y,Chiang SC.
Assessing Knowledge and Attitude of Healthcare Professionals on Biosimilars: A National Survey for Pharmacists and Physicians in Taiwan
. Healthcare (Basel)
.2021
;(9):1600-1610
|
|
| 16. |
2020
Pao CH,Ko Y.
An assessment of the psychometric properties of the Chinese version of the Gout Impact Scale
. Curr Med Res Opin
.2020
;(36):17-21
|
|
| 17. |
2020
Chou TC,Chiang SC,Ko Y.
Health state utilities for metastatic breast cancer in Taiwan
. Breast
.2020
;(51):57-64
|
|
| 18. |
2020
Chien CL,Chen YC,Malone DC,Peng YL,Ko Y.
Cost-utility analysis of second-line anti-diabetic therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin.
. Curr Med Res Opin
.2020
;(10):1619-1626
|
|
| 19. |
2020
Chen CC,Chen CL,Ko Y.
The Misconceptions and Determinants of Diabetes Knowledge in Patients with Diabetes in Taiwan.
. J Diabetes Res
.2020
|
|
| 20. |
2020
Chen YJ,Chen FL,Chen JH,Wu MM,Chien DS,Ko Y.
Costs and length of sepsis-related hospitalizations in Taiwan.
. Medicine
.2020
;(99):e20476
|
|
| 21. |
2020
Diaby V,Alqhtani H,van Boemmel-Wegmann S,Wang CY,Ali AA,Balkrishnan R, Ko Y, Palacio S, de Lima Lopes G.
A cost-effectiveness analysis of trastuzumab-containing treatment sequences for HER-2 positive metastatic breast cancer patients in Taiwan.
. Breast
.2020
;(49):141-148
|
|
| 22. |
2020
Lin HW,Chang EH,Ko Y,Wang CY,Wang YS,Mafruhah OR, Wu SH, Chen YC, Huang YM.
Conceptualization, Development and Psychometric Evaluations of a New Medication-Related Health Literacy Instrument: The Chinese Medication Literacy Measurement
. Int J Environ Res Public Health
.2020
;(17):6951-5967
|
|
| 23. |
2020
Wang LC,Kuo CN,Ko Y.
Cost-effectiveness analysis of trastuzumab emtansine (T-DM1) in treating HER-2 positive advanced breast cancer in Taiwan
. Breast J
.2020
|
|
| 24. |
2019
Lee YY,Kuo LN,Chen JH,Lin YC,Chen LF,Ko Y.
Prescribing patterns and healthcare costs of gout
. Curr Med Res Opin
.2019
;(35):1051-1058
|
|
| 25. |
2019
Cheng SW,Wang CY,Ko Y.
Costs and Length of Stay of Hospitalizations due to Diabetes-Related Complications
. J Diabetes Res
.2019
|
|
| 26. |
2019
Chen YJ,Chen FL,Chen JH,Wu MTM,Chen YL ,Chu YW, Chien DS, Ko Y.
Epidemiology of Sepsis in Taiwan
. Medicine
.2019
;(98):e15725
|
|
| 27. |
2019
Tseng KH,Chang EH,Ko Y.
An investigation of the determinants for community pharmacists' positive image and the needs for community pharmacists' services in Taiwan
. Int J Health Plann Manage
.2019
|
|
| 28. |
2018
Chi NF,Wang Y,Chien LN,Chien SC,Ko Y.
Healthcare costs and utilization of dabigatran compared to warfarin for secondary stroke prevention in patients with non-valvular atrial fibrillation: A retrospective population study
. Med Care
.2018
;(56):410-415
|
|
| 29. |
2018
Lee YY,Tang CH,Chen JH,Kuo LN,Ko Y.
Evaluation of healthcare costs and utilization for patients with gout: a population-based matched cohort study
. Curr Med Res Opin
.2018
;(34):735-740
|
|
| 30. |
2018
Lin YJ,Wang CY,Cheng SW,Ko Y.
Patient preferences for diabetes-related complications in Taiwan
. Curr Med Res Opin
.2018
;(35):7-13
|
|
| 31. |
2018
Siaw MYL,Malone DC,Ko Y,Lee JY.
Cost-effectiveness of multidisciplinary collaborative care versus usual care in the management of high-risk patients with diabetes in Singapore: Short-term results from a randomized controlled trial
. J Clin Pharm Ther
.2018
;(43):775-783
|
|
| 32. |
2018
Lin YJ,Wang CY,Chang EH,Cheng SW,Ko Y.
Translation, revision, and validation of the Chinese version of the Satisfaction with Oral Anti-Diabetic Agent Scale (C-SOADAS) in patients with type 2 diabetes mellitus
. Patient Prefer Adherence
.2018
;(12):667-672
|
|
| 33. |
2018
Cheng SW,Wang CY,Chen JH,Ko Y.
Healthcare costs and utilization of diabetes-related complications in Taiwan: A claims database analysis
. Medicine (Baltimore)
.2018
;(97):e11602-e11608
|
|
| 34. |
2017
Yeh YC,Lin HW,Chang EH,Huang YM,Chen YC,Wang CY, Liu JW, Ko Y.
Development and validation of a Chinese medication literacy measure
. Health Expectations
.2017
;(20):1296-1301
|
|
| 35. |
2017
Siaw MYL,Ko Y,Malone DC,Tsou KYK,Lew YJ,Foo D, Tan E, Chan SC, Chia A, Sinaram SS, Goh KC, Lee JY.
Impact of pharmacist-involved collaborative care on the clinical, humanistic and cost outcomes of high-risk patients with type 2 diabetes (IMPACT): a randomized controlled trial
. J Clin Pharm Ther
.2017
;(42):475-482
|
|
| 36. |
2017
Ng CS,Lau TC,Ko Y.
Cost of Osteoporotic Fractures in Singapore
. Value Health Reg Issues
.2017
;(12):27-35
|
|
| 37. |
2016
Wang Y,Yeo QQ,Ko Y.
Economic evaluations of pharmacist-managed services in people with diabetes mellitus: a systematic review
. Diabet Med
.2016
;(33):421-427
|
|
| 38. |
2015
Shuyu Ng C,Toh MP,Ko Y,Yu-Chia Lee J.
Direct medical cost of type 2 diabetes in singapore
. PLoS One
.2015
;(10):e01227
|
|
| 39. |
2015
Wang Y,Xie F,Kong MC,Lee LH,Ng HJ,Ko Y.
Patient-reported health preferences of anticoagulant-related outcomes
. Journal of Thrombosis and Thrombolysis
.2015
;(40):268-273
|
|
| 40. |
2015
Ng CS,Toh MP,Ng J,Ko Y.
Direct medical cost of stroke in Singapore
. Int J Stroke
.2015
;(10):75-82
|
|
| 41. |
2014
Wang Y,Kong MC,Lee LH,Ng HJ,Ko Y.
Knowledge, satisfaction, and concerns regarding warfarin therapy and their association with warfarin adherence and anticoagulation control
. Thromb Res
.2014
;(133):550-554
|
|
| 42. |
2014
Chan A,Soh D,Ko Y,Huang YC,Chiang J.
Characteristics of unplanned hospital admissions due to drug-related problems in cancer patients
. Support Care Cancer
.2014
;(22):1875-1881
|
|
| 43. |
2014
Tan XY,Aung MM,Ngai MI,Xie F,Ko Y.
Assessment of preference for hormonal treatment–related health states among patients with breast cancer
. ViHRI
.2014
;(3):27-32
|
|
| 44. |
2014
Ko Y,Gwee YS,Huang YC,Chiang J,Chan A.
Costs and length of stay of drug-related hospital admissions in cancer patients
. Clin Ther
.2014
;(3):588-592
|
|
| 45. |
2014
Ng CS,Lee JY,Toh MP,Ko Y.
Cost-of-illness studies of diabetes mellitus: A systematic review
. Diabetes Res Clin Pract
.2014
;(105):151-163
|
|
| 46. |
2014
Wang Y,Xie F,Kong MC,Lee LH,Ng HJ,Ko Y.
Cost-effectiveness of dabigatran and rivaroxaban compared with warfarin for stroke prevention in patients with atrial fibrillation
. Cardiovasc Drugs Ther
.2014
;(28):575-585
|
|
| 47. |
2013
Wang Y,Kong MC,Ko Y.
Comparison of three medication adherence measures in patients taking warfarin
. J Thromb Thrombolysis
.2013
;(36):416-421
|
|
| 48. |
2013
Ko Y,Lo NN,Yeo SJ,Yang KY,Yeo W,Chong HC, Thumboo J.
Comparison of the responsiveness of the SF-36, the Oxford Knee Score, and the Knee Society Clinical Rating System in patients undergoing total knee replacement
. Qual Life Res
.2013
;(22):2455-2459
|
|
| 49. |
2013
Ko Y,Devi Balasubramanian,Wong L,Tan ML,Lee E,Tang WE, Chan SC, Tan ASL, Toh MP HS.
Health literacy and its association with disease knowledge and control in patients with hypertension in Singapore
. Intl J Cardiology
.2013
;(168):e116-117
|
|
| 50. |
2012
Ko Y,Lee JY,Toh MP,Tang WE,Tan AS.
Development and validation of a general health literacy test in Singapore
. Health Promot Int
.2012
;(27):45-51
|
|
| 51. |
2012
Low JJ,Ko Y,Ilancheran A,Zhang XH,Singhal PK,Tay SK.
Health and economic burden of HPV-related diseases in Singapore
. Asian Pac J Cancer Prev
.2012
;(13):305-308
|
|
| 52. |
2012
Shih V,Chan A,Xie F,Ko Y.
Health state utility assessment for breast cancer
. ViHRI
.2012
;(1):93-97
|
|
| 53. |
2012
Shih V,Chan A,Xie F,Ko Y.
Economic evaluation of anastrozole versus tamoxifen for early stage breast cancer in Singapore
. ViHRI
.2012
;(1):46-53
|
|
| 54. |
2012
Shim YT,Lee J,Toh MP,Tang WE,Ko Y.
Health-related quality of life and glycaemic control in patients with Type 2 diabetes mellitus in Singapore
. Diabet Med
.2012
;(29):e241-248
|
|
| 55. |
2012
Wang Y,Lee J,Tang WE,Toh MP,Ko Y.
Validity and reliability of a self-reported meas ure of medication adherence in patients with Type 2 diabetes mellitus in Singapore
. Diabet Med
.2012
;(29):e338-344
|
|
| 56. |
2012
Ko Y,Tan SL,Chan A,Wong YP,Yong WP,Ng RCH, Lim SW, Salim A.
Prevalence of the co-prescription of clinically important interacting drug combinations involving oral anticancer agents: a retrospective database study
. Clin Ther
.2012
;(34):1696-1704
|
|
| 57. |
2012
Wang Y,Kong MC,Ko Y.
Psychometric properties of the 8-item Morisky Medication Adherence Scale in patients taking warfarin
. Thromb Haemost
.2012
;(108):789-795
|
|
| 58. |
2012
Koomanan N,Ko Y,Yong WP,Ng R,Wong YP,Lim SW, Salim A, Chan A.
Clinical impact of drug-drug interaction between aspirin and prednisolone at a cancer center
. Clin Ther
.2012
;(34):2259-2267
|
|
| 59. |
2011
Wong S,Lee J,Ko Y,Chong MF,Lam CK,Tang WE.
Perceptions of insulin therapy amongst Asian patients with diabetes in Singapore
. Diabet Med
.2011
;(28):206-211
|
|
| 60. |
2011
Ko Y,Narayanasamy S,Wee HL,Lo NN,Yeo SJ,ang KY, Yeo W, Chong HC, Thumboo J.
Health-related quality of life after total knee replacement or unicompartmental knee arthroplasty in an urban asian population
. Value Health
.2011
;(14):322-328
|
|
| 61. |
2011
Lua HL,Sklar G,Ko Y.
Identification and physicians' views of their commonly-used drug information sources in Singapore
. Int J Clin Pharm
.2011
;(33):772-778
|
|
| 62. |
2009
Lim YJ,Chan SY,Ko Y.
Stigma and health-related quality of life in Asian adults with epilepsy
. Epilepsy Res
.2009
;(87):107-119
|
|
| 63. |
2009
Luo N,Ko Y,Johnson JA,Coons SJ.
The association of survey language (Spanish vs. English) with Health Utilities Index and EQ-5D index scores in a United States population sample
. Qual Life Res
.2009
;(18):1377-1385
|
|
| 64. |
2009
Chan A,Tan SH,Wong CM,Yap KYL,Ko Y.
Clinically significant drug-drug interactions between oral anticancer agents and non-anticancer agents: a Delphi survey of oncology pharmacists
. Clin Ther
.2009
;(31):2379-2386
|
|
| 65. |
2009
Wong PS,Ko Y,Sklar GE.
Identification and evaluation of pharmacists' commonly used drug information sources
. Ann Pharmacother
.2009
;(43):347-352
|
|
| 66. |
2009
Ho CH,Ko Y,Tan ML.
Patient needs and sources of drug information in Singapore- is the internet replacing former sources?
. Ann Pharmacother
.2009
;(43):732-739
|
|
| 67. |
2009
Ko Y,Lo NN,Yeo SJ,Yang KY,Yeo W,Chong HC, Thumboo J.
Rasch analysis of the Oxford Knee Score
. Osteoarthritis Cartilage
.2009
;(17):1163-1169
|
|
| 68. |
2008
Ko Y,Malone DC,Skrepnek GH,Armstrong EP,Murphy JE,Abarca J, Rehfeld RA, Reel SJ, Woosley RL.
Prescribers' knowledge of and source for drug-drug interaction information
. Drug Saf
.2008
;(31):525-536
|
|
| 69. |
2008
Wong CM,Ko Y,Chan A.
Clinically significant drug-drug interactions between oral anticancer agents and non-anticancer agents: profiling and comparison of two drug compendia
. Ann Pharmacother
.2008
;(42):1737-1748
|
|
| 70. |
2008
Ko Y,Malone DC,D' Agostino JV,Skrepnek GH,Armstrong EP,Brown M, Woosley RL.
Potential determinants of prescribers' drug-drug interaction knowledge
. Res Social Adm Pharm
.2008
;(4):355-366
|
|
| 71. |
2007
Ko Y,Abarca J,Malone DC,Dare DC,Geraets D,Houranieh A, Jones WN, Nichol WP, Schepers GP, Wilhardt M.
Practitioners' views on computerized drug-drug interaction alerts in the VA system
. J Am Med Inform Assoc
.2007
;(14):56-64
|
|
| 72. |
2007
Mahmood M,Malone DC,Skrepnek GH,Abarca J,Armstrong EP,Murphy JE, Grizzle AJ, Ko Y, Woosley RL.
Potential drug-drug interactions within Veterans Affairs medical centers
. Am J Health Syst Pharm
.2007
;(64):1500-1505
|
|
| 73. |
2007
Grizzle AJ,Mahmood M,Ko Y,Murphy JE,Armstrong EP,Skrepnek GH, Jones WN, Schepers GP, Nichol WP, Houranieh A, Dare DC, Hoey CT, Malone DC.
Reasons Provided by Prescribers when overriding drug-drug interaction alerts
. Am J Manag Care
.2007
;(13):573-580
|
|
| 74. |
2006
Brown M,Frost R,Ko Y.
Diagramming patients’ views of root causes of adverse drug events in ambulatory care: an online tool for planning education and research
. Patient Educ Couns
.2006
;(62):302-315
|
|
| 75. |
2006
Ko Y,Coons SJ.
Self-reported chronic conditions and EQ-5D index scores in the US adult population
. Curr Med Res Opin
.2006
;(22):2065-2071
|
|
| 76. |
2006
Ko Y,Brown M,Woosley R,Woosley R.
Development of a prescription medication information webliography for consumers
. J Gen Intern Med
.2006
;(21):1313-1316
|
|
| 77. |
2006
Ko Y,Malone DC,Armstrong EP.
A pharmacoeconomic evaluation of antimuscarinic agents for the treatment of overactive bladder
. Pharmacotherapy
.2006
;(26):1694-1702
|
|
| 78. |
2005
Ko Y,Lin SJ,Salmon JW,Bron MS.
The impact of urinary incontinence on quality of life of the elderly
. Am J Manag Care
.2005
;(11):S103-S111
|
|
| 79. |
2005
Ko Y,Coons SJ.
An examination of self-reported chronic conditions and health status in the 2001 Medicare Health Outcomes Survey
. Curr Med Res Opin
.2005
;(21):1801-1808
|
|